Institute of Applied Dermatopharmacy, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Eur J Pharm Biopharm. 2010 Feb;74(2):219-22. doi: 10.1016/j.ejpb.2009.11.009. Epub 2009 Nov 20.
Microemulsions (MEs) and mixed micelles (MMs) have been used as new drug formulations for high hydrophilic drugs such as cefpirom and cefodizim for oral administration. Cefpirom and cefodizim are neither actively nor passively transported across cell membranes. Up to date, they can be only administrated intravenously (i.v.) or intramuscularly (i.m.). The rabbit (Chinchilla) in vivo model was used in the present work to investigate ways of overcoming the poor oral absorption of these cephalosporins. The cephalosporins at 100mg/kg were formulated in MEs and MMs and administered intraduodenally (i.d.). Very low bioavailability (2.5-3.0%) was observed, if cefpirom or cefodizim i.d. were applied without colloidal vehicle. However, the addition of the cephalosporins to ME or MM is shown to be highly effective in increasing the bioavailability values (up to 64% absolute bioavailability) of the model drugs. In conclusion, MEs and MMs improve essentially the oral bioavailability of the high hydrophilic drugs.
微乳液 (MEs) 和混合胶束 (MMs) 已被用作新的药物制剂,用于口服高亲水性药物,如头孢匹罗和头孢地嗪。头孢匹罗和头孢地嗪既不能主动也不能被动地穿过细胞膜。到目前为止,它们只能静脉注射 (i.v.) 或肌肉注射 (i.m.)。本工作采用兔 (Chinchilla) 体内模型研究克服这些头孢菌素口服吸收不良的方法。将头孢菌素以 100mg/kg 的剂量制成 ME 和 MM,并经十二指肠内给药 (i.d.)。如果没有胶体载体,头孢匹罗或头孢地嗪 i.d. 给药,其生物利用度非常低(2.5-3.0%)。然而,将头孢菌素加入 ME 或 MM 中被证明可非常有效地提高模型药物的生物利用度值(高达 64%的绝对生物利用度)。总之,MEs 和 MMs 可显著提高高亲水性药物的口服生物利用度。